The Efficacy of Intravenous Hydroxocobalamin Versus Methylene Blue as Treatment for Intraoperative Vasoplegic Syndrome in Liver Transplant Patients
Phase: PHASE4
Conditions: Vasoplegic Syndrome, Liver Transplant; Complications
Sponsor: Mayo Clinic

 
 
The Efficacy of Intravenous Hydroxocobalamin 
Versus Methylene Blue as Treatment for 
Intraoperative Vasoplegic Syndrome in Liver 
Transplant Patients 
 
NCT04054999 
 
11DEC2019